Enterolactone
Product Specifications
UNSPSC Description
Enterolactone is a bioactive phenolic metabolite known as a mammalian lignan derived from dietary lignans. Enterolactone has estrogenic properties and anti-breast cancer activity[1]. Enterolactone is a radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis[2].
Target Antigen
Apoptosis; Endogenous Metabolite
Type
Natural Products
Related Pathways
Apoptosis;Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/enterolactone.html
Purity
99.0
Solubility
DMSO : 30 mg/mL (ultrasonic;warming)
Smiles
O=C1OC[C@H](CC2=CC=CC(O)=C2)[C@H]1CC3=CC=CC(O)=C3
Molecular Weight
298.33
References & Citations
[1]Bigdeli B, et al. Enterolactone: A novel radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis. Toxicol Appl Pharmacol. 2016;313:180-194.|[2]Mali AV, et al. Enterolactone modulates the ERK/NF-κB/Snail signaling pathway in triple-negative breast cancer cell line MDA-MB-231 to revert the TGF-β-induced epithelial-mesenchymal transition. Cancer Biol Med. 2018;15(2):137-156.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-108692/Enterolactone-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-108692/Enterolactone-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
78473-71-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1119936-01 0.02 mg (E-Coli)
Recombinant Cyanothece sp. UPF0296 protein cce_4590 (cce_4590)
Ask
View Details MBS1119936-02 0.1 mg (E-Coli)
Recombinant Cyanothece sp. UPF0296 protein cce_4590 (cce_4590)
Ask
View Details 
MBS1119936-03 0.02 mg (Yeast)
Recombinant Cyanothece sp. UPF0296 protein cce_4590 (cce_4590)
Ask
View Details